Concept DHA (US Pharmaceutical Corporation)


Welcome to the PulseAid listing for the Concept DHA drug offered from US Pharmaceutical Corporation. This Nicotinic Acid [EPC],Nicotinic Acids [Chemical/Ingredient],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Copper [Chemical/Ingredient],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: US Pharmaceutical Corporation
NON-PROPRIETARY NAME: Vitamin- Mineral Omega-3 Supplement
SUBSTANCE NAME: FERROUS FUMARATE; IRON; ASCORBIC ACID; FOLIC ACID; THIAMINE MONONITRATE; RIBOFLAVIN; NIACIN; CALCIUM PANTOTHENATE; PYRIDOXINE HYDROCHLORIDE; BIOTIN; CYANOCOBALAMIN; CUPRIC SULFATE; MAGNESIUM SULFATE;
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Nicotinic Acid [EPC],Nicotinic Acids [Chemical/Ingredient],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Copper [Chemical/Ingredient],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, LIQUID FILLED
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2009-06-24
END MARKETING DATE: 0000-00-00


Concept DHA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionConcept DHA from US Pharmaceutical Corporation
LABELER NAME: US Pharmaceutical Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 53.5; 38; 25; 1; 2; 3; 1.8; 5; 25; 300; 12.5; 2; 5; 10; 200(mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1)
START MARKETING DATE: 2009-06-24
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52747-621_de12d125-2cc8-4993-817c-8663b5b7e1f2
PRODUCT NDC: 52747-621
APPLICATION NUMBER:

Other FERROUS FUMARATE; IRON; ASCORBIC ACID; FOLIC ACID; THIAMINE MONONITRATE; RIBOFLAVIN; NIACIN; CALCIUM PANTOTHENATE; PYRIDOXINE HYDROCHLORIDE; BIOTIN; CYANOCOBALAMIN; CUPRIC SULFATE; MAGNESIUM SULFATE; Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
US Pharmaceutical CorporationConcept OB